Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Fungal Genet Biol ; 140: 103368, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32201128

RESUMEN

Ergosterol is the most important membrane sterol in fungal cells and a component not found in the membranes of human cells. We identified the ERG6 gene in the AIDS-associated fungal pathogen, Cryptococcus neoformans, encoding the sterol C-24 methyltransferase of fungal ergosterol biosynthesis. In this work, we have explored its relationship with high-temperature growth and virulence of C. neoformans by the construction of a loss-of-function mutant. In contrast to other genes involved in ergosterol biosynthesis, C. neoformans ERG6 is not essential for growth under permissive conditions in vitro. However, the erg6 mutant displayed impaired thermotolerance and increased susceptibility to osmotic and oxidative stress, as well as to different antifungal drugs. Total lipid analysis demonstrated a decrease in the erg6Δ strain membrane ergosterol content. In addition, this mutant strain was avirulent in an invertebrate model of C. neoformans infection. C. neoformans Erg6 was cyto-localized in the endoplasmic reticulum and Golgi complex. Our results demonstrate that Erg6 is crucial for growth at high temperature and virulence, likely due to its effects on C. neoformans membrane integrity and dynamics. These pathogen-focused investigations into ergosterol biosynthetic pathway components reinforce the multiple roles of ergosterol in the response of diverse fungal species to alterations in the environment, especially that of the infected host. These studies open perspectives to understand the participation of ergosterol in mechanism of resistance to azole and polyene drugs. Observed synergistic growth defects with co-inhibition of Erg6 and other components of the ergosterol biosynthesis pathway suggests novel approaches to treatment in human fungal infections.


Asunto(s)
Criptococosis/genética , Cryptococcus neoformans/genética , Ergosterol/biosíntesis , Metiltransferasas/genética , Antifúngicos/farmacología , Azoles/farmacología , Vías Biosintéticas/efectos de los fármacos , Criptococosis/tratamiento farmacológico , Criptococosis/microbiología , Cryptococcus neoformans/patogenicidad , Retículo Endoplásmico/efectos de los fármacos , Ergosterol/genética , Regulación Fúngica de la Expresión Génica/efectos de los fármacos , Humanos , Mutación/efectos de los fármacos , Virulencia/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA